Major clinical research advances in gynecologic cancer in 2011

This publication has 66 references indexed in Scilit:

• Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial
  The Lancet Oncology, 2012
• Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial
  The Lancet Oncology, 2012
• Effect of the Gonadotropin-Releasing Hormone Analogue Triptorelin on the Occurrence of Chemotherapy-Induced Early Menopause in Premenopausal Women With Breast Cancer
  JAMA, 2011
• Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice
  The Lancet Oncology, 2011
• Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study
  The Lancet, 2011
• Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study
  The Lancet, 2011
• Personalized estimates of breast cancer risk in clinical practice and public health
  Statistics in Medicine, 2011
• Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study
  The Lancet, 2009
• A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass
  Gynecologic Oncology, 2009
• 2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests
  American Journal of Obstetrics and Gynecology, 2007